{"References": [{"title": "Mechanisms of resistance to CAR T cell therapy", "authors": "Majzner RG, Mackall CL", "journal": "Nature Reviews Clinical Oncology", "year": "2019", "volumes": "16", "first page": "372", "last page": "385", "DOI": "10.1038/s41571-019-0184-6"}, {"title": "Intrinsic and extrinsic resistance mechanisms to CAR T-cell therapy", "authors": "Sterner RC, Sterner RM", "journal": "Journal of Hematology & Oncology", "year": "2021", "volumes": "14", "first page": "94", "last page": "108", "DOI": "10.1186/s13045-021-01107-1"}, {"title": "Overcoming resistance to CAR T-cell therapy in hematologic malignancies", "authors": "Brudno JN, Kochenderfer JN", "journal": "Blood", "year": "2016", "volumes": "127", "first page": "3321", "last page": "3328", "DOI": "10.1182/blood-2016-02-629063"}, {"title": "CAR T-cell therapy: current limitations and potential strategies", "authors": "Fesnak AD, June CH, Levine BL", "journal": "Blood", "year": "2016", "volumes": "127", "first page": "3321", "last page": "3331", "DOI": "10.1182/blood-2015-11-672956"}, {"title": "Resistance mechanisms to CAR T-cell therapy and approaches to overcome them", "authors": "Rafiq S, Hackett CS, Brentjens RJ", "journal": "International Journal of Molecular Sciences", "year": "2020", "volumes": "21", "first page": "765", "last page": "785", "DOI": "10.3390/ijms21030765"}, {"title": "CAR T-cell therapy: challenges and opportunities in hematologic malignancies", "authors": "Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y", "journal": "Journal of Clinical Oncology", "year": "2017", "volumes": "35", "first page": "2021", "last page": "2032", "DOI": "10.1200/JCO.2016.71.3024"}, {"title": "CAR T-cell therapy: a game changer in cancer treatment", "authors": "June CH, Sadelain M", "journal": "Cell", "year": "2018", "volumes": "173", "first page": "37", "last page": "42", "DOI": "10.1016/j.cell.2018.03.036"}, {"title": "Mechanisms of resistance to CAR T cell therapy in large B-cell lymphoma", "authors": "Chong EA, Ruella M, Schuster SJ", "journal": "The Lancet Oncology", "year": "2019", "volumes": "20", "first page": "e683", "last page": "e693", "DOI": "10.1016/S1470-2045(19)30673-6"}, {"title": "CAR T-cell therapy: the path to successful cancer treatment", "authors": "Sadelain M, Brentjens R, Rivi√®re I", "journal": "Nature Reviews Cancer", "year": "2013", "volumes": "13", "first page": "370", "last page": "383", "DOI": "10.1038/nrc3516"}, {"title": "CAR T-cell therapy: a new era in cancer immunotherapy", "authors": "Porter DL, Levine BL, Kalos M, Bagg A, June CH", "journal": "Nature Reviews Clinical Oncology", "year": "2011", "volumes": "8", "first page": "317", "last page": "327", "DOI": "10.1038/nrclinonc.2011.38"}]}